SCHEMBL17275482

SCHEMBL17275482

CC(N)C(=O)Cn1cc(C(N)=O)nn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 1/20 0.47
CA5A P35218 1/20 0.47
SMYD3 Q9H7B4 1/20 0.39
MAPK1 P28482 2/20 0.38
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
GLA P06280 1/20 0.35
GPR88 Q9GZN0 1/20 0.35
SRC P12931 2/20 0.35
DPP4 P27487 1/20 0.34
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
NOS2 P35228 1/20 0.33
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17275479 1.00 SCD (0.47) SCDCA5ASMYD3MAPK1MEN1
SCHEMBL28626933 0.82 SCD (0.43) SCDCA5ASMYD3MAPK1MEN1
SCHEMBL28626936 0.82 SCD (0.43) SCDCA5ASMYD3MAPK1MEN1
SCHEMBL17275464 0.81 SCD (0.42) SCDCA5ASMYD3MAPK1MEN1
SCHEMBL18680932 0.76 SCD (0.54) SCDCA5ASMYD3MAPK1GLA
SCHEMBL17282916 0.76 SCD (0.38) SCDCA5ASMYD3MAPK1MEN1
SCHEMBL28150957 0.75 SMYD3 (0.32) SMYD3MAPK1MEN1TSHRKMT2A
SCHEMBL10642640 0.73 SCD (0.54) SCDCA5ASMYD3GPR88DPP4
SCHEMBL18680934 0.72 SCD (0.50) SCDCA5ASMYD3GPR88ALDH1A1
SCHEMBL23675961 0.71 MAPK1 (0.37) SCDCA5ASMYD3MAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106661084-B Macrocyclic broad spectrum antibiotics 阿奇克斯制药公司 2021-08-31 CN disclosed
EP-3145944-B1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2021-05-05 EP disclosed
US-10392422-B2 Macrocyclic broad spectrum antibiotics RQX PHARMACEUTICALS, INC. (US) 2019-08-27 US disclosed
US-10351595-B2 2019-07-16 US disclosed
CN-106661084-A Macrocyclic broad spectrum antibiotics 阿奇克斯制药公司 2017-05-10 CN disclosed
US-20170088582-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS, INC. (US) 2017-03-30 US disclosed
EP-3145944-A2 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX Pharmaceuticals, Inc. (US) 2017-03-29 EP disclosed
WO-2015179441-A2 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS, INC. (US) 2015-11-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351595-B2 MRPL21, PRSS1, PEPD SCD 1272/4885CA5A 3897/4885SMYD3 2525/4885
US-10392422-B2 Macrocyclic broad spectrum antibiotics MRPL21, PEPD, CTSC SCD 1558/4885CA5A 4391/4885SMYD3 3191/4885
US-20170088582-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC SCD 1558/4885CA5A 4391/4885SMYD3 3191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.